CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 48 enrolled
Drug / intervention
SurePace Powered Walker Userdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05465239
NCT05465239N/ACompleted
CompareCT.gov

Intelligent and Adaptive Control Applied to Powered Walkers

Barron Associates, Inc.·interventional·Posted Jul 19, 2022·Updated Jan 14, 2025

In Brief

A clinical study evaluating SurePace Powered Walker User for Cerebral Palsy. Completed, enrolled 48 participants across 1 site.

Detailed Summary

The research is towards an advanced control and computer learning strategy that will intelligently drive a powered walker for people with walking disabilities. The aim of the control strategy is to provide powered assistance that optimally reduces the metabolic cost of walking. The goal of the proposed intelligent walker is to reduce the workload of walking, keeping this population walking longer, providing critical exercise, continued muscle development and improved quality of life.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebral Palsy
CountriesUnited States
CollaboratorsUniversity of Virginia, National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJul 19, 2022
Enrollment StartDec 1, 2020
Primary CompletionSep 30, 2023
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 4.0 years ago

Interventions

SurePace Powered Walker Userdevice

Participants will be asked to perform one baseline 5-minute trial with the lab's instrumented walker in passive mode (no powered locomotion) and two 5-minute trials with the walker in active mode (powered locomotion).